Related references
Note: Only part of the references are listed.SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer
Yangmei Zhang et al.
CELL CYCLE (2020)
MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling
Jue Jiang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway
Xianfu Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro
Yangyang Han et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt/β-catenin signaling pathway
Chao Wang et al.
CELL DEATH & DISEASE (2019)
Knockdown of IncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway
Yi Chen et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
被撤回的出版物: Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma (Retracted article. See vol. 49, pg. 679, 2021)
Shaosong Huang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
The functions and unique features of long intergenic non-coding RNA
Julia D. Ransohoff et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Long noncoding RNA SNHG7 accelerates prostate cancer proliferation and cycle progression through cyclin D1 by sponging miR-503
Honggang Qi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Diagnosing pituitary adenoma in unstained sections based on multiphoton microscopy
Peihua Lin et al.
PITUITARY (2018)
Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours
Ze Rui Wu et al.
NATURE COMMUNICATIONS (2018)
Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52)
Zhiling Zhang et al.
ONCOLOGY RESEARCH (2017)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
miR-449 overexpression inhibits papillary thyroid carcinoma cell growth by targeting RET kinase-β-catenin signaling pathway
Zongyu Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Management of clinically non-functioning pituitary adenoma
Philippe Chanson et al.
ANNALES D ENDOCRINOLOGIE (2015)
Low Expression of miR-449 in Gynecologic Clear Cell Carcinoma
Sang-Geun Jang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
被撤回的出版物: MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1 (Retracted article. See vol. 63, 2023)
Hongyi Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression
Yantian Fang et al.
ONCOLOGY REPORTS (2013)
MicroRNA-449a Is Downregulated in Non-Small Cell Lung Cancer and Inhibits Migration and Invasion by Targeting c-Met
Wenting Luo et al.
PLOS ONE (2013)
Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
Reena Buurman et al.
GASTROENTEROLOGY (2012)
ROLE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 MUTATIONAL ANALYSIS IN CLINICAL PRACTICE
Paul J. Newey et al.
ENDOCRINE PRACTICE (2011)
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Tony Bou Kheir et al.
MOLECULAR CANCER (2011)
RNA maps reveal new RNA classes and a possible function for pervasive transcription
Philipp Kapranov et al.
SCIENCE (2007)
The prevalence of pituitary adenomas - A systematic review
S Ezzat et al.
CANCER (2004)
Share Paper
